Funding

Dr. Roberts has received funding for research in his Hepatobiliary Cancer Laboratory from a variety of organizations, including the National Institutes of Health, the Robert Wood Johnson Foundation, the American Gastroenterological Association Research Foundation, the American College of Gastroenterology and the Cholangiocarcinoma Foundation.

Investigator & Role Grant Title Funding Source Duration
Lewis R. Roberts, M.B., Ch.B., Ph.D., principal investigator Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (CA186566) National Institutes of Health 04/10/15-03/31/20
Lewis R. Roberts, M.B., Ch.B., Ph.D., principal investigator The role of the gut microbiome in the progression of liver cirrhosis Swedish Research Council Research Links Grant 01/01/16-12/31/18
Lewis R. Roberts, M.B., Ch.B., Ph.D., co-investigator Extracellular non-coding RNA biomarkers of hepatocellular cancer (TR000884-01) National Institutes of Health 09/01/13-08/31/18
  • Ju Dong Yang, M.D., principal investigator
  • Lewis R. Roberts, M.B., Ch.B., Ph.D., mentor
Discovery and validation of novel DNA methylation markers for the detection of perihilar cholangiocarcinoma American College of Gastroenterology Clinical Research Award 07/01/17-06/30/18
Lewis R. Roberts, M.B., Ch.B., Ph.D., co-investigator Regulation of molecular thermal ablative resistance in hepatocellular carcinoma (CA177686) National Institutes of Health 07/01/17-06/30/18
Lewis R. Roberts, M.B., Ch.B., Ph.D., co-leader Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention (Cancer Prevention Network; CPN) (CN35000-11-0-1) National Institutes of Health 09/24/12-9/23/17
  • Ju Dong Yang, M.D., principal investigator
  • Lewis R. Roberts, M.B., Ch.B., Ph.D., mentor
Control of stellate cells-driven liver cancer by the p62/NBR1 adapters American College of Gastroenterology Clinical Research Award 07/01/16-06/30/17
  • Katsuyuki Miyabe, M.D., Ph.D., principal investigator
  • Lewis R. Roberts, M.B., Ch.B., Ph.D., mentor
The role of the biliary and gut microbiome in the progression of cholangiocarcinoma and primary sclerosing cholangitis American College of Gastroenterology Clinical Research Award 07/01/16/-6/30/17
Lewis R. Roberts, M.B., Ch.B., Ph.D., principal investigator Detection of actionable or predictive tumor DNA mutations in peripheral blood (liquid biopsy) from patients with cholangiocarcinoma Mayo Clinic Cancer Center Fraternal Order of Eagles Pilot Award for Cancer Research 07/01/16/-6/30/17
Lewis R. Roberts, M.B., Ch.B., Ph.D., principal investigator Early Detection Research Network (EDRN) Hepatocellular Carcinoma Early Detection Strategy Study (HEDS) (CA86402) National Institutes of Health 09/01/12-06/30/17
Lewis R. Roberts, M.B., Ch.B., Ph.D., associate director, predoctoral programs-M.D. Mayo Clinic Center for Clinical and Translational Science (CCaTS) (CA86402) National Institutes of Health 07/01/11-06/30/17
Lewis R. Roberts, M.B., Ch.B., Ph.D., principal investigator International Cholangiocarcinoma Research Network The Cholangiocarcinoma Foundation 03/01/16-02/28/17